2-3 years MBB or straight to industry?

Hi, so I would really like to get some more insight into this one issue that has kept me on the fence about consulting or going straight into industry.

A little background first: I'm a second year MBA at a top 10 school and I'm sitting on an offer from one of the MBB firms as well as from a top tier US pharma company. The pharma career is an 4 year MBA rotation program, after which, with good performance, I should land in a director role. MBB, well, I'd try to shoot for partner, but lets be honest, very very few get that far.

So I'm trying to understand what happens when/if I get out at 2-3 years.

Background research on this and other forums points to people trying to get into PE. Great, but it looks like that is also generally a long shot. MBB and the forums tout that every year in consulting = 2 years in industry, you'll get so many more skills, and when you exit you'll be way ahead of your peers. So if you don't do PE and go into industry after consulting, you'll be a leg up...

But talking with a very small group of alumni that I've been able to reach out to it seems: One went straight into an auto manufacturer after MBA and said that his progress has been much better than peers who went to MBB and then tried to enter the same auto company. Another alumni spent 2 years at an MBB firm then went to a different pharma company and sees his position as behind those of his classmates.

Very anecdotal evidence, but it's all I have to work on that is tangible as opposed to the generic "oh you'll do great after consulting." Anyone know of others who left consulting at the 2-3 year mark and was it a help or a hindrance?

 

In UG heading into IB so this is pure opinion- take it for what you will.

I feel like the smarter move would be pharma if you want to end up in that industry. If you want to go to a different industry, aren't sure of what you want to do, or really want to try and make partner, consulting becomes the obvious choice. To try and turn that into a more specific answer for your question- based on intuition, and your anecdotes, I think you'll be slightly behind the curve if you go consulting to industry as opposed to starting in the same industry, so if you want to work in healthcare my bet would be go right there. Again: in UG going into IB so I have no actual experience with this- take it for what you will.

 

Limited data sample (N=5), but for those who left at engagement manager/project leader (N=3) or principal/associate principal (N=2), they went onto Senior Director or VP position at F500 (different industries). Tenure at firm ranged from 4-8 years.

Look at your alumni's linkedin profile, and check his/her connections. Let me know if you find more anecdotes besides your two alumni you know of.

Also, I would just check job postings for Director positions in big pharma, see what the requirements are. From postings at companies I looked at, some have preference for management consulting.

 

Great info! Based on the above post and some web searching, it looks like to get the full benefit, one would have to make it to at least the engagement manager level.

Usually companies don't post their higher level positions for access to the whole internet, but its worth a search. I'll take a look into that in more detail tomorrow and see if I get generate some trends, especially in the industries I'd like to target (automotive and pharma - I know, very different, but two areas that really interest me)

The other data point I have is my internship company - it's a F500 heavy construction machinery company. I don't think any of the director or VP level folks I've interacted with came from consulting. Some senior management folks were pulled from the auto industry, but that's about as much external recruitment as I've seen. This company mainly recruits straight from undergrad, very sporadic MBA recruiting, and some poaching higher levels from other heavy construction/automotive/occasionally aero.

 
Best Response

You can usually find postings (at least in big pharma) for associate director/director online.

Here's an example from some of the big pharmas that I found: Novartis (Director of Strategy): 15+ years experience, ideally in consulting with a top tier consulting firm and/or relevant pharmaceutical or consumer products industry experience

Pfizer (Director of Strategy): Ten years pharmaceutical, Biotech and /or Commercial pharmaceutical Industry experience with demonstrated leadership experience and/or 2-3 years in Management Consulting role with focus on pharmaceutical industry

BMS (Director of Strategic Analytics) - 5 or more years of experience in a company or academia (or combination) in a function such as market research, strategic planning, finance, marketing, portfolio management or strategic consulting

Seems like it can go either way, but I would assume you should specialize in your industry of choice as soon as you can.

 

Thanks for that above. I was going to hit that research tomorrow, still will do some more digging, but that's truly helpful.

The Pfizer role seems like exactly what I would hope to find after a few years at a MBB firm if I were to get out. Again, I think my goal would actually be to shoot for partner. That's at least one more data point that shows that opportunities are generally in line with what they tout.

It also just hit me that our program maintains a very comprehensive database of alums with many profiles that include direct LinkedIn connections. A little research shows that a significant amount of people from '05-'09 did go to MBB and about 1/2 seemed to stayed in and reached a high level. As I examined those currently in industry positions, all of those who showed MBB as their post-MBA start point were at least at a director level - though this trend seems to happen only for specific industries. As significant number of '05-'09 grads who were directors in pharma and tech appeared to have spent at 2-4 years consulting first, though about as many directors went straight into industry. I did not find a single instance (of linkedin profiles that were available) of alumni in aero, automotive, or heavy manufacturing at high levels and went into consulting first.

So, it looks like the answer to my initial question is "it should be fine." Will still do more research over the next few days. Question now is really - do I want to do consulting or pharma?

 

Cool. That makes sense. Director is pretty decent position, so I would think you need at least 3-4 years experience post MBA.

You may get a head start in pharma with the rotation program, but MBB may just be better from a network standpoint. 5 years from now, your next position will probably be through contacts. I would think with such high turnover, you're more likely to run into a fellow MBB alumni, than whichever pharma you may join now.

For me, would also depend on which pharma it is. Probably won't miss too much by going to MBB for 3-4 years (and you can explore auto industry), unless your offer is with a really up and coming pharma/biopharma, such as Regeneron (leading on PCSK9), Gilead who dominates infectious diseases, or even BMS who is in the lead with immunotherapies (CLTA-4 recently approved, leading on PD-1).

Good luck with your decision.

 

i would say go pharma.. there is a clearer view of your end goal and you are going into a rotational program. Its less of a gamble than going into MBB, hoping you survive the up and out policy, hoping you get staffed on pharma projects that you can relate to a pharma interview that you hope you land after 2 years or so.

 

Have you worked in pharma before? It is a totally different animal compared to consulting.

Either way, you cannot really make a wrong decision GSK Espirit Program (I'm assuming) vs MBB

PM if you have any specific questions, worked in pharma and have talked to many ex-consultants in pharma

 

Minima repellat dolorem quidem molestiae perspiciatis est consectetur. Debitis sed necessitatibus rerum maiores nesciunt non. Voluptatem reprehenderit sit itaque enim voluptatem labore.

Quia consequatur sit et et quo magnam. Odit in omnis dolore non molestiae aut. Illo quibusdam voluptatem est dolorem ipsa non. Quam dolor aliquid hic iusto aut et.

Career Advancement Opportunities

April 2024 Consulting

  • Bain & Company 99.4%
  • McKinsey and Co 98.9%
  • Boston Consulting Group (BCG) 98.3%
  • Oliver Wyman 97.7%
  • LEK Consulting 97.2%

Overall Employee Satisfaction

April 2024 Consulting

  • Bain & Company 99.4%
  • Cornerstone Research 98.9%
  • Boston Consulting Group (BCG) 98.3%
  • McKinsey and Co 97.7%
  • Oliver Wyman 97.2%

Professional Growth Opportunities

April 2024 Consulting

  • Bain & Company 99.4%
  • McKinsey and Co 98.9%
  • Boston Consulting Group (BCG) 98.3%
  • Oliver Wyman 97.7%
  • LEK Consulting 97.2%

Total Avg Compensation

April 2024 Consulting

  • Partner (4) $368
  • Principal (25) $277
  • Director/MD (55) $270
  • Vice President (47) $246
  • Engagement Manager (100) $226
  • Manager (152) $170
  • 2nd Year Associate (158) $140
  • Senior Consultant (331) $130
  • 3rd+ Year Associate (108) $130
  • Consultant (587) $119
  • 1st Year Associate (538) $119
  • NA (15) $119
  • 3rd+ Year Analyst (146) $115
  • Engineer (6) $114
  • 2nd Year Analyst (344) $103
  • Associate Consultant (166) $98
  • 1st Year Analyst (1048) $87
  • Intern/Summer Associate (188) $84
  • Intern/Summer Analyst (552) $67
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Betsy Massar's picture
Betsy Massar
99.0
5
CompBanker's picture
CompBanker
98.9
6
kanon's picture
kanon
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”